Getting Ozempic requires a prescription from a licensed medical provider, and the specific path depends on whether you have type 2 diabetes or are seeking it primarily for weight loss. The process involves a medical evaluation, meeting certain eligibility criteria, navigating insurance coverage, and filling the prescription at a pharmacy. Here’s how each step works.
What Ozempic Is Approved For
Ozempic (semaglutide) is FDA-approved specifically for adults with type 2 diabetes. Its three approved uses are improving blood sugar control alongside diet and exercise, reducing the risk of major cardiovascular events like heart attack and stroke in people with type 2 diabetes and heart disease, and protecting kidney function in people with type 2 diabetes and chronic kidney disease.
Weight loss is not an approved indication for Ozempic, even though the drug does cause significant weight reduction. Wegovy, which contains the same active ingredient at a higher dose, is the version approved for weight management. That said, doctors can and do prescribe Ozempic off-label for weight loss, particularly when Wegovy is unavailable or not covered by a patient’s insurance.
Who Qualifies for a Prescription
If you have type 2 diabetes, qualifying is straightforward. Your provider will confirm your diagnosis and determine whether Ozempic is appropriate based on your current treatment plan, blood sugar levels, and other health factors.
For weight management (off-label or through a related semaglutide product), providers typically require one of two things: a BMI of 30 or higher, or a BMI of 27 or higher combined with at least one weight-related health condition such as high blood pressure, high cholesterol, type 2 diabetes, sleep apnea, or heart disease. These thresholds aren’t rigid legal requirements, but they reflect the clinical guidelines most prescribers follow and that insurance companies use to determine coverage.
How to Get the Prescription
Several types of providers can prescribe Ozempic: primary care doctors, nurse practitioners, physician assistants, and endocrinologists. You don’t need to see a specialist. At your visit, your provider will take your weight and blood pressure, ask about your medical and family history, and review any current medications. Blood work to check your blood sugar (and often kidney and thyroid function) is standard before starting.
Telehealth is a legitimate option. Many providers can evaluate you and write a prescription through a virtual visit, though some may require at least one in-person appointment for baseline measurements and lab work. Several telehealth platforms now specialize in GLP-1 prescriptions, but make sure any service you use connects you with a licensed provider in your state who conducts a genuine medical evaluation rather than just rubber-stamping a prescription.
What Happens After You’re Prescribed
Ozempic is a once-weekly injection you give yourself using a prefilled pen. You inject it under the skin of your abdomen, thigh, or upper arm on the same day each week, at whatever time is convenient, with or without food.
Your dose increases gradually over several months. You’ll start at 0.25 mg weekly for the first four weeks. This is not a therapeutic dose; it’s designed to let your body adjust and minimize side effects like nausea. After four weeks, your dose increases to 0.5 mg. From there, your provider may keep you at 0.5 mg or increase to 1 mg or eventually 2 mg (the maximum), depending on how you respond. Each step up typically lasts at least four weeks before the next increase. Most people reach their maintenance dose within two to three months.
Insurance Coverage and Prior Authorization
Insurance coverage for Ozempic varies widely and has become more complicated in recent years. If you have a type 2 diabetes diagnosis, most commercial plans cover it, though many now require prior authorization. The rate of prior authorization requirements for semaglutide products jumped from below 15% in mid-2023 to over 80% by mid-2024 across Medicare Part D plans, and commercial insurers have followed a similar trend.
Prior authorization means your provider needs to submit documentation proving you meet the plan’s criteria before the pharmacy can fill it. This often includes evidence that you’ve tried other diabetes medications first (called step therapy), your current blood sugar levels, and sometimes records showing you’ve attempted lifestyle changes. The process can take anywhere from a few days to a few weeks. If your initial request is denied, your provider can file an appeal.
Getting coverage for off-label weight loss use is harder. Many plans exclude GLP-1 medications for weight management entirely, and Medicare Part D does not cover any drugs prescribed solely for obesity. If your plan denies coverage, you’re looking at paying out of pocket or exploring assistance programs.
What It Costs
The list price of Ozempic is roughly $900 to $1,000 per month without insurance. Novo Nordisk, the manufacturer, offers a savings program that can significantly reduce this.
If you have commercial insurance that covers Ozempic, the savings card brings your copay down to as little as $25 for up to a three-month supply, with a cap of $100 in savings per month. This benefit lasts up to 48 months.
If you’re uninsured or paying out of pocket, the pricing through Novo Nordisk’s pharmacy program is $349 per month for the 0.25 mg, 0.5 mg, or 1 mg doses, and $499 per month for the 2 mg dose. New patients can get the first two months at $199 per month for the lower doses, though this introductory offer has specific enrollment windows. These savings programs are not available to anyone on government insurance, including Medicare, Medicaid, and Tricare. However, Federal Employees Health Benefits plans, Affordable Care Act marketplace plans, and state employee plans do qualify.
Availability at the Pharmacy
Ozempic experienced significant supply shortages through 2023 and 2024, but the FDA declared the semaglutide shortage resolved in February 2025. As of mid-2025, all dose strengths are available, though Novo Nordisk has discontinued the 0.25 mg and 0.5 mg doses in the older 2 mg/1.5 mL pen presentation. If a specific pharmacy is temporarily out of stock, calling other locations or asking your pharmacist to check distributor availability usually resolves it quickly. Specialty pharmacies and mail-order pharmacies connected to your insurance plan are also options.
Avoid Compounded Versions
During the shortage, compounding pharmacies began producing their own semaglutide formulations, and many still market them online at lower prices. These products carry real risks. The FDA has received reports of hospitalizations tied to dosing errors with compounded semaglutide, with patients accidentally injecting five to twenty times the intended dose because of confusing vial concentrations and measurement conversions.
Some compounders use salt forms of semaglutide (semaglutide sodium or semaglutide acetate) rather than the base form used in the approved drug. The FDA has stated it is not aware of any legal basis for compounding with these alternate forms. Others add ingredients like vitamin B-12, L-carnitine, or NAD to their formulations, and the safety of combining semaglutide with these additives has not been established. Now that the shortage is resolved, the FDA’s position is that compounded semaglutide should not be used when the approved product is available.
If you encounter an online service offering semaglutide without a genuine medical evaluation, at prices that seem too low, or shipped from outside the United States, treat it as a red flag. Counterfeit and substandard products are a documented problem in the injectable medication market.